Carl P. Sherr & Co’s Bristol-Myers Squibb BMY Stock Holding History

Carl P. Sherr & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$205K	Sell	3,552 -3,916	-52%	-$225K	0.09%	131
2026 Q1	$453K	Buy	7,468 +532	+8%	+$31K	0.21%	80
2025 Q4	$382K	Buy	+6,936	New	+$334K	0.17%	91
2023 Q4	–	Sell	-7,469	Closed	-$433K	–	116
2023 Q3	$433K	Hold	7,469	–	–	0.29%	75
2023 Q2	$478K	Hold	7,469	–	–	0.31%	73
2023 Q1	$518K	Hold	7,469	–	–	0.37%	65
2022 Q4	$537K	Buy	7,469 +130	+2%	+$9.8K	0.41%	62
2022 Q3	$522K	Hold	7,339	–	–	0.42%	61
2022 Q2	$565K	Buy	7,339 +300	+4%	+$22.8K	0.42%	62
2022 Q1	$514K	Sell	7,039 -300	-4%	-$20.1K	0.35%	75
2021 Q4	$458K	Buy	7,339 +75	+1%	+$4.4K	0.28%	82
2021 Q3	$430K	Hold	7,264	–	–	0.34%	63
2021 Q2	$485K	Hold	7,264	–	–	0.33%	71
2021 Q1	$459K	Sell	7,264 -1,007	-12%	-$62.7K	0.35%	72
2020 Q4	$513K	Sell	8,271 -50	-0.6%	-$3.07K	0.41%	71
2020 Q3	$502K	Hold	8,321	–	–	0.45%	68
2020 Q2	$489K	Hold	8,321	–	–	0.49%	67
2020 Q1	$464K	Hold	8,321	–	–	0.55%	62
2019 Q4	$534K	Buy	+8,321	New	+$477K	0.52%	64

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Carl P. Sherr & Co's BMY Position: Q2 2026 in Review

Carl P. Sherr & Co reduced its Bristol-Myers Squibb (BMY) stake by 52% in Q2 2026, selling an estimated $225K and leaving 3,552 shares worth $205K. The position accounts for 0.09% of the portfolio, ranked #131.

Carl P. Sherr & Co first reported a position in BMY in Q4 2019 and has held it in 19 quarters since. The position peaked at $565K in Q2 2022. 2,523 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Carl P. Sherr & Co held 3,552 shares of Bristol-Myers Squibb worth $205K as of Q2 2026.
Carl P. Sherr & Co sold 3,916 Bristol-Myers Squibb shares in Q2 2026, an estimated $225K.
Bristol-Myers Squibb made up 0.09% of Carl P. Sherr & Co's portfolio in Q2 2026, its #131 holding.
Carl P. Sherr & Co first reported a position in Bristol-Myers Squibb in Q4 2019 and has held it in 19 quarters since.
Carl P. Sherr & Co's Bristol-Myers Squibb position peaked at $565K in Q2 2022.
2,523 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Carl P. Sherr & Co's 13F filing for Q2 2026, filed 3 Aug 2026.